Stock Comparison
REGN vs TECH
Regeneron Pharmaceuticals Inc and Bio-Techne Corp side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$66.35B
$11.06B
P/E (TTM)
15.5
101.4
Forward P/E
14.1
34.8
Price/Sales
4.5
9.1
Price/Book
2.1
5.3
EV/EBITDA
10.5
43.3
Dividend Yield
0.58%
0.45%
Profitability
Net Margin
29.60%
9.05%
Operating Margin
20.70%
25.20%
Return on Equity
14.50%
5.34%
Return on Assets
6.13%
7.45%
Growth (YoY)
Revenue Growth
19.00%
-1.50%
Earnings Growth
-7.20%
128.60%
Price & Risk
Beta
0.2
1.4
52-Week High
$818.90
$71.93
52-Week Low
$516.07
$43.12
Analyst Target
$833.31
$65.75
Compare REGN and TECH your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.